XML 109 R65.htm IDEA: XBRL DOCUMENT v3.23.4
Summary of Significant Accounting Policies - Schedule of balance sheet are reconcile (FY) (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Schedule of Balance Sheet are Reconcile [Abstract]        
Gross proceeds     $ 189,750,000  
Less:        
Proceeds allocated to Public Warrants     (4,204,248)  
Common stock issuance costs $ (184,845,836) (7,701,178)  
Plus:        
Accretion of redeemable common stock     1,877,984 $ 13,802,926
Contingently redeemable common stock $ 10,620,981   $ 193,525,484 $ 191,647,500